Market Cap
$105.6B
SYK
STRYKER CORP
$275.88 ▲ +1.07%
Prev close $272.96Market cap$105.6B
ConsensusBuy
12-mo target$367.80 (+33.3%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (3 insiders)High Impact Filing (8/10)37 New Institutional Positions13 Institutional ExitsCongressional Activity (1) Healthcare & Medical Devices
Snapshot
The big-picture read on SYK right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Strong Buy (79%)
Inst. Holders
50 funds
Inst. Value
$67.2B
Inst. Activity
37 buys / 13 sells
Insider Activity
$0.00 buy / $218.9M sell
Insider Net $
-$218.9M
Social Sentiment
71° Bullish
SEC Reports
13
Press Releases
3
Congressional
5 trades
Price chart 30d -11.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 other
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (
Sep 24, 2026 Insider
Wells Preston Wendell disposed of 109 shares
VP, Chief Financial Officer
Sep 22, 2026 Insider
Wells Preston Wendell disposed of 962 shares
VP, Chief Financial Officer
Sep 15, 2026 Event
Aug 31, 2026 Press Bully Dawgs Towing LLC v. Stryker et al
Court ruling (ohsd) — Docket: 2:26-mc-00022
Stryker acquired privately-held ZuriMED and its FiberLocker System for rotator cuff augmentation. The deal enhances Stry
Impact 4/10
Three Stryker insiders, including a director and two senior executives, sold a combined $1.74M in open-market sales over
CLUSTER — Impact 2/10
Director Ronda E. Stryker sold ~$118M in SYK shares over two days (Aug 18-19), representing ~0.09% of market cap. A seco
CLUSTER — Impact 3/10
Aug 21, 2026 Insider
Crotty Dylan Bram sold 441 shares
Group President @ $328.61 ($144.9K)
Analyst ratings buy % +12.9%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
79% rate it Buy or better · 34 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 30, 2026 | Stifel | MAINTAIN | Buy | 54% |
| Sep 22, 2026 | TD Cowen | MAINTAIN | Hold | 56% |
| Sep 18, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| Sep 10, 2026 | Citigroup | MAINTAIN | Buy | 55% |
| Sep 9, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Aug 13, 2026 | Wolfe Research | DOWNGRADE | Peer Perform | 52% |
| Aug 3, 2026 | Citizens | MAINTAIN | Market Outperform | 38% |
| Jul 31, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Jul 31, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Jul 31, 2026 | Piper Sandler | MAINTAIN | Overweight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 12 | 15 | 7 | 0 | 0 | 79% | |
| Aug 1, 2026 | 13 | 15 | 6 | 0 | 0 | 82% | |
| Jul 1, 2026 | 13 | 14 | 8 | 0 | 0 | 77% | |
| Jun 1, 2026 | 13 | 14 | 8 | 0 | 0 | 77% | |
| May 1, 2026 | 13 | 15 | 9 | 0 | 0 | 76% | |
| Apr 1, 2026 | 12 | 15 | 9 | 0 | 0 | 75% | |
| Mar 1, 2026 | 12 | 16 | 9 | 0 | 0 | 76% | |
| Feb 1, 2026 | 11 | 16 | 9 | 0 | 0 | 75% |
Price targets
Where 25 covering analysts think SYK trades over the next 12 months.
$367.80 +33.3% upside Strong Buy
Current$275.88 Low$298.00 Median$360.00 High$465.00 25 analysts
$298.00$465.00
Analyst rating Buy· 1.7/5 as of Oct 2, 2026
Social media sentiment mood -11.7%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
71°
Bullish
BearishNeutralBullish
Recent posts
SYK at a 9% disocunt today, betting quick recovery
▲ 1 · 💬 0· ⚡ 0.5
SYK down today almost 9%, betting quick recovery, but curious if it's going to dip a bit more
▲ 1 · 💬 1· ⚡ 0.5
Stryker Corp (SYK) slides ~9% after CFO comments at Wells Fargo conf
▲ 1 · 💬 0· ⚡ 0.5
What quality compounders fit this portfolio?
▲ 1 · 💬 7· ⚡ 0.5
Medtech, Medtronic are gaining
▲ 1 · 💬 0· ⚡ 0.5
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
13 SEC filing reports analyzed · 6 bullish, 1 bearish, 0 mixed, 6 neutral · avg impact 3.8/10.Plus 3 press releases.
BULLISHANALYST-UPGRADE3/10
BMO Capital Initiates SYK at Outperform — PT $369 (+12.9%)
Jul 9, 2026
NEUTRALCLUSTER2/10
Three Stryker insiders, including a director and two senior executives, sold a combined $1.74M in op
Aug 27, 2026
NEUTRALCLUSTER3/10
Director Ronda E. Stryker sold ~$118M in SYK shares over two days (Aug 18-19), representing ~0.09% o
Aug 21, 2026
BULLISHCOURT-RULING6/10
Stryker won dismissal of Treace Medical's antitrust (Sherman Act, Clayton Act, state antitrust) and
Jul 14, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
other
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
SAN FRANCISCO, Oct. 1, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (NYSE: SYK) saw the price of their shares fall $26.
Oct 1, 2026
earnings
Stryker to announce third quarter 2026 financial results
Portage, Michigan, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, October 29, 2026
Sep 24, 2026
other
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Stryker Corp. ("Stryker" or the "Company") (N
Sep 17, 2026
other
Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
SAN FRANCISCO, Sept. 17, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (NYSE: SYK) saw the price of their shares fall $2
Sep 16, 2026
short_volume
Short Volume: SYK — 67.8% short (0.9M / 1.3M)
Short: 915,727 | Exempt: 1,204 | TRF Vol: 1,349,912 | Short Ratio: 67.8% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $3.57 | $3.44–$3.80 | 11.9% | -0.6% | 1↑ 21↓ | $6.6B | 24 |
| Next Q | $5.14 | $4.98–$5.23 | 14.9% | -0.3% | 8↑ 11↓ | $8.0B | 24 |
| Current FY | $14.99 | $14.90–$15.07 | 10.0% | -0.2% | 20↑ 3↓ | $27.2B | 27 |
| Next FY | $16.72 | $16.38–$17.08 | 11.6% | -0.2% | 17↑ 6↓ | $29.6B | 27 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $3.569 | — |
| 7d ago | $3.572 | -0.002 |
| 30d ago | $3.590 | -0.021 |
| 60d ago | $3.564 | +0.005 |
| 90d ago | $3.685 | -0.115 |
Institutional ownership
Which big funds own SYK (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $67.2B total value (212,345,763 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, JPMORGAN. Net buying activity: 37 institutions added/increased vs 13 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 27,414,742 | $8.6B | 12.8% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 22,536,843 | $7.1B | 10.6% | — |
| JPMORGAN CHASE & CO | 17,260,943 | $5.7B | 8.5% | — |
| STATE STREET CORP | 15,532,565 | $4.9B | 7.3% | — |
| GREENLEAF TRUST | 15,228,545 | $4.8B | 7.1% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8,173,167 | $2.6B | 3.8% | — |
| WELLINGTON MANAGEMENT GROUP LLP | 8,167,185 | $2.6B | 3.8% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 7,819,802 | $2.5B | 3.6% | — |
| MORGAN STANLEY | 5,960,732 | $1.9B | 2.8% | — |
| ALLIANCEBERNSTEIN L.P. | 4,927,021 | $1.6B | 2.4% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 4,892,615 | — | $1.5B |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 1,555,638 | 3,282,207 | +111.0% | $1.0B |
| AMERIPRISE FINANCIAL INC | DOUBLED | 1,406,695 | 3,272,554 | +132.6% | $1.0B |
| SCHRODER INVESTMENT MANAGEMENT GROUP | ADD | 1,377,172 | 2,119,907 | +53.9% | $667.4M |
| FMR LLC | TRIM | 2,364,394 | 1,702,373 | -28.0% | $536.0M |
| Capital Research Global Investors | TRIM | 5,612,389 | 1,617,176 | -71.2% | $509.2M |
| FLOSSBACH VON STORCH SE | DOUBLED | 539,538 | 1,475,371 | +173.5% | $464.5M |
| Clearbridge Investments, LLC | TRIM | 1,699,484 | 1,183,466 | -30.4% | $372.6M |
| 1832 Asset Management L.P. | ADD | 922,234 | 1,156,684 | +25.4% | $364.2M |
| Boston Partners | DOUBLED | 841 | 1,071,198 | +127271.9% | $337.0M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
9 insiders, 50 transactions. Net -$218.9M — $0.00 bought, $218.9M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Wells Preston Wendell | VP, Chief Financial Officer | J | 109 | — | — |
| Sep 22, 2026 | Wells Preston Wendell | VP, Chief Financial Officer | J | 962 | — | — |
| Aug 21, 2026 | Crotty Dylan Bram | Group President | SELL | 441 | $328.61 | $144.9K |
| Aug 19, 2026 | STRYKER RONDA E | Director | SELL | 320 | $336.79 | $107.8K |
| Aug 19, 2026 | STRYKER RONDA E | Director | SELL | 40 | $331.81 | $13.3K |
| Aug 19, 2026 | STRYKER RONDA E | Director | SELL | 80 | $335.06 | $26.8K |
| Aug 19, 2026 | STRYKER RONDA E | Director | SELL | 11,257 | $338.90 | $3.8M |
| Aug 19, 2026 | STRYKER RONDA E | Director | SELL | 200 | $333.93 | $66.8K |
| Aug 19, 2026 | STRYKER RONDA E | Director | SELL | 2,308 | $337.98 | $780.1K |
| Aug 19, 2026 | STRYKER RONDA E | Director | SELL | 16,612 | $340.71 | $5.7M |
Congressional trades
SYK trades disclosed by members of Congress, with disclosure delay.
3 members · 1 buys / 4 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Thomas Kean Jr | R | HOUSE | SELL | $1,001 - $15,000 | Stryker Corp | Aug 19, 2026(29d) |
| Jun 2, 2026 | Thomas Kean Jr | R | HOUSE | SELL | $1,001 - $15,000 | Stryker Corp | Jul 16, 2026(45d) |
| Apr 13, 2026 | Ro Khanna | D | HOUSE | BUY | $15,001 - $50,000 | Stryker Corp | May 13, 2026(31d) |
| Mar 27, 2026 | Alan Armstrong | R | SENATE | SELL | $15,001 - $50,000 | Stryker Corp | Jul 22, 2026(117d) |
| Jan 23, 2026 | Thomas Kean Jr | R | HOUSE | SELL | $15,001 - $50,000 | Stryker Corp | Feb 20, 2026(29d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SYK.
Shares short
7,671,881
Settlement Sep 15, 2026
Change vs prior
+0.4%
Semi-monthly cycle
Days to cover
2.2
At avg daily volume
Of shares outstanding
≈2.0%
Estimate — not % of float
All SYK filing & press-release reports (16)
- BMO Capital Initiates SYK at Outperform — PT $369 (+12.9%)Jul 9, 2026
- PRESS-RELEASE reportAug 31, 2026
- CLUSTER reportAug 27, 2026
- CLUSTER reportAug 21, 2026
- COURT-RULING reportJul 14, 2026
- COURT-RULING reportJul 4, 2026
- COURT-RULING reportJul 4, 2026
- COURT-RULING reportJul 2, 2026
- 8-K reportJun 26, 2026
- CLUSTER reportJun 2, 2026
- CLUSTER reportMay 29, 2026
- PRESS-RELEASE reportApr 30, 2026
- COURT-RULING reportApr 30, 2026
- PRESS-RELEASE reportApr 13, 2026
- PRESS-RELEASE reportApr 1, 2026
- DEFA14A reportMar 23, 2026